Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Appointed director
CC transcript
Credit agrmnt [a]

WEST PHARMACEUTICAL SERVICES INC (WST) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Reiss-Clark Cindy (Chief Commercial Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 3,477 shares @ $393.34, valued at $1.4M
Exercised 777 options to buy @ $369.13, valued at $286.8k
Exercised 1,588 options to buy @ $274.29, valued at $435.6k
Exercised 1,112 options to buy @ $173.22, valued at $192.6k
08/15/2023 4 Lai Quintin J (VP Strat & Investor Relations) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 10,725 shares @ $394.6225, valued at $4.2M
Sold 8,635 shares @ $395.5426, valued at $3.4M
Sold 1,741 shares @ $396.123, valued at $689.7k
Exercised 8,772 options to buy @ $89.64, valued at $786.3k
Exercised 7,140 options to buy @ $102.51, valued at $731.9k
Exercised 3,348 options to buy @ $173.22, valued at $579.9k
Exercised 1,388 options to buy @ $274.29, valued at $380.7k
Exercised 453 options to buy @ $369.13, valued at $167.2k
08/11/2023 4 Witherspoon Charles (VP & Treasurer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 1,680 shares @ $396.54, valued at $666.2k
Exercised 840 options to buy @ $173.22, valued at $145.5k
Exercised 840 options to buy @ $102.51, valued at $86.1k
08/10/2023 4 Abraham Silji (SVP, Chief Technology Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 8,154 shares @ $397.1776, valued at $3.2M
Sold 6 shares @ $397.69, valued at $2.4k
Exercised 8,160 options to buy @ $102.51, valued at $836.5k
08/10/2023 4 Green Eric Mark (President & CEO) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 1,000 shares @ $389.62, valued at $389.6k
Sold 4,500 shares @ $392.1553, valued at $1.8M
Sold 7,055 shares @ $393.131, valued at $2.8M
Sold 8,329 shares @ $394.174, valued at $3.3M
Sold 7,684 shares @ $395.0733, valued at $3M
Sold 6,700 shares @ $396.1253, valued at $2.7M
Sold 7,532 shares @ $397.1762, valued at $3M
Sold 1,100 shares @ $397.8964, valued at $437.7k
Sold 100 shares @ $398.87, valued at $39.9k
Exercised 50,000 options to buy @ $57.38, valued at $2.9M
08/08/2023 144 Form 144 - Report of proposed sale of securities:
08/08/2023 4 Birkett Bernard (Sr VP, Chief Fin & Ops Off) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 22,134 shares @ $370.3809, valued at $8.2M
Sold 200 shares @ $371.025, valued at $74.2k
Exercised 8,450 options to buy @ $102.51, valued at $866.2k
Exercised 13,884 options to buy @ $100.92, valued at $1.4M
07/27/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/27/2023 8-K Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits  I...
Docs: "West Announces Second-Quarter 2023 Results - Conference Call Scheduled for 9 a.m. EDT Today -",
"YTD Q2 2022 YTD Q2 2023"
06/28/2023 11-K Form 11-K - Annual report of employee stock purchase, savings and similar plans:
06/28/2023 11-K Form 11-K - Annual report of employee stock purchase, savings and similar plans:
05/31/2023 4 Witherspoon Charles (VP & Treasurer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 1,000 shares @ $343.05, valued at $343.1k
Exercised 1,000 options to buy @ $102.51, valued at $102.5k
05/31/2023 4 Winters Chad (VP, Chief Accounting Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Exercised 872 shares @ $339.51, valued at $296.1k
Exercised 872 options to buy @ $143.43, valued at $125.1k
05/25/2023 SD Form SD - Specialized disclosure report:
05/11/2023 4 Green Eric Mark (President & CEO) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 14,157 shares @ $361.9468, valued at $5.1M
Sold 12,562 shares @ $362.9267, valued at $4.6M
Sold 12,648 shares @ $363.9354, valued at $4.6M
Sold 4,133 shares @ $364.7645, valued at $1.5M
Sold 500 shares @ $365.458, valued at $182.7k
Exercised 50,000 options to buy @ $57.38, valued at $2.9M
05/09/2023 144 Form 144 - Report of proposed sale of securities:
05/09/2023 4 Winters Chad (VP, Chief Accounting Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Paid exercise price by delivering 10 shares @ $368.46, valued at $3.7k
05/02/2023 4 Hofmann Thomas W (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 1,212 shares @ $365.575, valued at $443.1k
05/02/2023 4 Abraham Silji (SVP, Chief Technology Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 7,371 shares @ $365.5532, valued at $2.7M
Sold 649 shares @ $366.1385, valued at $237.6k
Exercised 8,020 options to buy @ $86.24, valued at $691.6k
05/02/2023 4 Favorite Annette F (Sr. VP & Chief HR Officer) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Sold 9,425 shares @ $365.4683, valued at $3.4M
Sold 2,687 shares @ $366.4632, valued at $984.7k
Sold 900 shares @ $367.4527, valued at $330.7k
Exercised 13,012 options to buy @ $59.64, valued at $776k
05/01/2023 144 Form 144 - Report of proposed sale of securities:
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2023 4 FRIEL ROBERT F (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Granted 616 shares @ $0
04/27/2023 4 Pucci Paolo (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Granted 616 shares @ $0
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2023 4 Joseph Molly (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Granted 616 shares @ $0
04/27/2023 4 Keller Deborah L (Director) has filed a Form 4 on WEST PHARMACEUTICAL SERVICES INC
Txns: Granted 616 shares @ $0
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/27/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/27/2023 8-K Quarterly results
03/28/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy